InsidersTradesSigma
Track the Alphamab Oncology - B share price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Market capitalisation: €6.7bn. The latest transaction was disclosed on 23 June 2026 (Purchase). Among the most active insiders: XU TING. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Alphamab Oncology - B is a company focused on developing innovative treatments for cancer. It specializes in the research and commercialization of therapies based on monoclonal antibodies.